Tuesday, November 24, 2009, 3:18pm EST - Canadian Markets close in 42 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

United Therapeutics Corp. (UTHR)

 At 15:03 EST: 45.515 USD  Up 0.815 (1.82%)  
MORE ON UTHR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
United Therapeutics Corporation (NasdaqNM:UTHR) Delayed quote dataEdit
Last Trade: 45.515 USD
Trade Time: 3:03PM EST
Change: Up 0.815 (1.82%)
Prev Close: 44.70
Open: 44.70
Bid: 45.51 x 200
Ask: 45.52 x 200
1y Target Est: 54.07
Day's Range: 44.61 - 45.53
52wk Range: 24.31 - 99.83
Volume: 259,630
Avg Vol (3m): 617,143
Market Cap: 2.45B
P/E (ttm): N/A
EPS (ttm): -1.02
Div & Yield: N/A (N/A%)
United Therapeutics Corp. (UTHR)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add UTHR to Portfolio   Download Data

HEADLINES
• UNITED THERAPEUTICS CORP Financials
EDGAR Online Financials (Tue, Nov 3)
• United Therapeutics Misses
Zacks.com (Mon, Nov 2)
• Q3 2009 United Therapeutics Earnings Release - Before Market Open
CCBN (Thu, Oct 29)
• UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, Oct 29)
• United Therapeutics Corporation Reports Third Quarter 2009 Financial Results - Revenues of $97.2 Million, Compared to $75.0 Million for Third
PRNewswire (Thu, Oct 29)
• REFILE-U.S. female CEOs' pay fell more than men's-survey
at Reuters (Mon, Oct 26)
• Women CEOs lag in compensation study
at bizjournals.com (Mon, Oct 26)
• United Therapeutics Corporation to Announce Third Quarter 2009 Financial Results Before Market Open on Thursday, October 29, 2009
PRNewswire (Thu, Oct 22)
• UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Sep 18)
• United Therapeutics splits stock
at bizjournals.com (Wed, Sep 2)
• United Therapeutics approves 2-for-1 stock split
AP (Tue, Sep 1)
More Headlines for UTHR...
ANALYST
EPS Est (next year) (Dec-09) : 0.69
EPS Est (in 2 years) (Dec-10) : 1.63
Avg Rec (current)*: 1.8
PEG Ratio: 1.57
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening cardiovascular and infectious diseases, and cancer in the United Stat...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices